About the journal
Biomedicines is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,600 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2227-9059
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,600 CHF
- Articles in DOAJ
- 17488
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.mdpi.com/journal/biomedicines
Index listings
- DOAJ · 2014-06-23
- PUBMED · 2013-03-11
- Indexing
- DOAJ · PUBMED
- APC
- 2,600 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
17488
Most recent article
last month
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
17207
Last recorded publication year
2026
h-index
128
i10-index
6612
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-10
- Added to DOAJ
- 2014-06-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 95%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101691304
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Gut microbiota and health
- Gut microbiota and health
- Cancer Immunotherapy and Biomarkers
- Extracellular vesicles in disease
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Extracellular vesicles in disease
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Mesenchymal stem cell research
- Immune cells in cancer
- Mesenchymal stem cell research
- Immune cells in cancer
- Cancer, Hypoxia, and Metabolism
- Epigenetics and DNA Methylation
- Cancer, Hypoxia, and Metabolism
- Epigenetics and DNA Methylation
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Ferroptosis and cancer prognosis
- Adipose Tissue and Metabolism
- Adipose Tissue and Metabolism
- Ferroptosis and cancer prognosis
- RNA modifications and cancer
- RNA modifications and cancer
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Diet and metabolism studies
- Diet and metabolism studies
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Diabetes Treatment and Management
- Immune Cell Function and Interaction
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
Keywords (DOAJ)
- biological active substances
- quality and safety of biological pharmaceutical products
- gene therapy
- challenges in administration of biomedicines
- development of biomedicines
- production of biomedici
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ